Logo
x

Search

Subscribe Now

Shorla Oncology

Shorla Oncology Reports the US FDA’s Expanded Approval of Jylamvo for Pediatric Indications

Shorla Oncology Reports the US FDA’s Expanded Approval of Jylamvo for Pediatric Indications

  • October 30, 2024
Shorla Oncology Reports the Acquisition of Jylamvo from Therakind Targeting Oncology and Autoimmune Indications

Shorla Oncology Reports the Acquisition of Jylamvo from Therakind Targeting Oncology and Autoimmune Indications

  • November 1, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.